SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $495K invested in Scinai Immunotherapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$391K
2
+$82K
3
+$13K
4
TRCT
Tower Research Capital (TRC)
New York
+$6K
5
Citigroup
Citigroup
New York
+$3K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$391K
2
$82K
3
$13K
4
$6K
5
$3K